Created at Source Raw Value Validated value
Dec. 15, 2020, 2:47 p.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "When renal acute support is indicated; patients will be submitted to a block randomization process through the Randomization.com website and allocated into 2 groups: Early Indication Group: indication of RAS regardless of acute kidney injury (AKI) stage; Standard indication Group: RAS indication when the presence of demand and renal capacity imbalance is identified. Within each group a second randomization will be performed: Prolonged Intermittent Hemodialysis: characterized by blood and dialysate flows of 200 mL / min and 300 mL / min; respectively; and duration of 6 hours; Continuous venovenous hemodialysis (HDC): defined as a 24-hour continuous treatment that uses blood and dialysate flows between 100-150 mL / min and 1000-1500 mL / hour; respectively. Regional anticoagulation will be performed with 4% trisodium citrate and M100 hemofilter will be used.;Procedure/surgery;E05.196.353", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "Early indication", "treatment_id": 1102, "treatment_name": "Renal dialysis", "treatment_type": "Life support", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "Standard indication", "treatment_id": 1102, "treatment_name": "Renal dialysis", "treatment_type": "Life support", "pharmacological_treatment": "Non pharmacological treatment"}]

Oct. 26, 2020, 8:29 a.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "When renal acute support is indicated; patients will be submitted to a block randomization process through the Randomization.com website and allocated into 2 groups: Early Indication Group: indication of RAS regardless of acute kidney injury (AKI) stage; Standard indication Group: RAS indication when the presence of demand and renal capacity imbalance is identified. Within each group a second randomization will be performed: Prolonged Intermittent Hemodialysis: characterized by blood and dialysate flows of 200 mL / min and 300 mL / min; respectively; and duration of 6 hours; Continuous venovenous hemodialysis (HDC): defined as a 24-hour continuous treatment that uses blood and dialysate flows between 100-150 mL / min and 1000-1500 mL / hour; respectively. Regional anticoagulation will be performed with 4% trisodium citrate and M100 hemofilter will be used.;Procedure/surgery;Dialysis", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]